Citigroup’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-100
| Closed | – | – | 7999 |
|
|
2019
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 8043 |
|
|
2018
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 8064 |
|
|
2018
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 8044 |
|
|
2018
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 7934 |
|
|
2018
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 7871 |
|
|
2017
Q4 | $0 | Sell |
100
-1,604
| -94% | -$6.98K | ﹤0.01% | 7827 |
|
|
2017
Q3 | $7K | Buy |
1,704
+34
| +2% | +$138 | ﹤0.01% | 6800 |
|
|
2017
Q2 | $5K | Buy |
1,670
+936
| +128% | +$3.88K | ﹤0.01% | 6776 |
|
|
2017
Q1 | $7K | Buy |
734
+134
| +22% | +$1.18K | ﹤0.01% | 6724 |
|
|
2016
Q4 | $5K | Sell |
600
-250
| -29% | -$2.3K | ﹤0.01% | 6957 |
|
|
2016
Q3 | $10K | Sell |
850
-2,744
| -76% | -$31.9K | ﹤0.01% | 6559 |
|
|
2016
Q2 | $45K | Sell |
3,594
-11,420
| -76% | -$139K | ﹤0.01% | 5644 |
|
|
2016
Q1 | $152K | Buy |
15,014
+2,044
| +16% | +$24K | ﹤0.01% | 5345 |
|
|
2015
Q4 | $292K | Buy |
12,970
+6,218
| +92% | +$127K | ﹤0.01% | 4389 |
|
|
2015
Q3 | $112K | Sell |
6,752
-6,973
| -51% | -$140K | ﹤0.01% | 4900 |
|
|
2015
Q2 | $309K | Sell |
13,725
-521
| -4% | -$12.8K | ﹤0.01% | 4107 |
|
|
2015
Q1 | $367K | Sell |
14,246
-5,713
| -29% | -$145K | ﹤0.01% | 4020 |
|
|
2014
Q4 | $435K | Buy |
19,959
+10,670
| +115% | +$219K | ﹤0.01% | 4010 |
|
|
2014
Q3 | $176K | Buy |
9,289
+254
| +3% | +$5.1K | ﹤0.01% | 4327 |
|
|
2014
Q2 | $211K | Buy |
9,035
+6,066
| +204% | +$150K | ﹤0.01% | 4086 |
|
|
2014
Q1 | $100K | Sell |
2,969
-1,273
| -30% | -$42.9K | ﹤0.01% | 4992 |
|
|
2013
Q4 | $125K | Buy |
+4,242
| New | +$77.7K | ﹤0.01% | 5069 |
|
Citigroup's OMED Position: Q2 2019 in Review
Citigroup sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 100 shares.
Citigroup first reported a position in OMED in Q4 2013 and held it in 22 quarters. The position peaked at $435K in Q4 2014. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- Citigroup reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Citigroup sold 100 OncoMed Pharmaceuticals, Inc. shares in Q2 2019.
- Citigroup first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2013 and held it in 22 quarters.
- Citigroup's OncoMed Pharmaceuticals, Inc. position peaked at $435K in Q4 2014.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.